Sign up Australia
Proactive Investors - Run By Investors For Investors

Liberum ups Unilever price target on “solid progress” towards 2020 targets but it’s still not a fan

Liberum’s new price target for Unilever is 4,200p, more than 100p below its current price
unilever website
The City broker has concerns over full-year organic sales growth

Liberum has upped its price target for Unilever PLC (LON:ULVR), claiming that the Anglo-Dutch drugs giant is making “solid progress” towards its 2020 goals.

The FTSE 100-group wants to restore its operating margins back up to 20% come 2020, while it is also looking to make €6bn in cost savings by then.

READ: Unilever H1 sales rise

Last week, Unilever reported that its underlying operating margin rose 80 basis points to 18.6% as it trimmed its cost base.

Liberum is upbeat and has upped its price target to 4,200p (from 3,960p) over what it sees as progress towards the 2020 goals, although it’s still not the biggest fan of the stock, maintaining its ‘hold’ recommendation.

“We forecast acceleration in 2H organic sales growth to 3.6% as one-off factors drop out, yet this implies only c.3% organic sales growth in 2018,” read the note to clients.

“Underlying margin progress of 50bps in 2018 and the second tranche of the €6bn share buyback underpin our forecast for 4.5% 2018E EPS growth.”

Unilever shares are up 0.5% to 4,305p in late morning trading.

View full ULVR profile View Profile

Unilever plc Timeline

Related Articles

cake
April 17 2018
The group's major shareholders have staunchly supported the business while the AIM-listed group sorts out its financial position

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use